BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6098261)

  • 1. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of the development of pertussis vaccine.
    Pittman M
    Dev Biol Stand; 1991; 73():13-29. PubMed ID: 1778306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 6. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MH; Britsina MV; Shmeleva EI; Mertsalova NU; Ermolova EI; Sukhinova EE; Bulk VF; Sirotinskiĭ AV; Poluiianova AG; Sviridov VV; Vartanian IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):67-70. PubMed ID: 9304334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and histopathology of pertussis: implications for immunization.
    Cherry JD; Paddock CD
    Expert Rev Vaccines; 2014 Sep; 13(9):1115-23. PubMed ID: 24992986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic approaches to a vaccine for pertussis.
    Nencioni L; Pizza M; Volpini G; Podda A; Rappuoli R
    Adv Exp Med Biol; 1991; 303():119-27. PubMed ID: 1805560
    [No Abstract]   [Full Text] [Related]  

  • 10. Acellular pertussis vaccines.
    Poltera AA
    N Engl J Med; 1996 Jun; 334(23):1547; author reply 1547-8. PubMed ID: 8618620
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of improved pertussis vaccine.
    Rumbo M; Hozbor D
    Hum Vaccin Immunother; 2014; 10(8):2450-3. PubMed ID: 25424954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Whooping cough].
    Bos SE
    Ned Tijdschr Geneeskd; 1984 Jul; 128(30):1409-11. PubMed ID: 6089007
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolation and purification of a preparation possessing leukocytosis-stimulating properties from pertussis bacteria].
    Trofimova NP; Demina AA; Igonina IuA; Dolomanova MS; Syresina GI
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):78-82. PubMed ID: 190830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Developmental trends in pertussis vaccines].
    Milleck J; Ocklitz HW
    Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1285-7. PubMed ID: 4335598
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
    Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 19. Further contributions to an improved pertussis vaccine: I. Molecular mechanisms of pertussis toxin.
    Aktories K; Jakobs KH; Robbel L
    Behring Inst Mitt; 1984 Nov; (76):106-9. PubMed ID: 6098260
    [No Abstract]   [Full Text] [Related]  

  • 20. Pertussis and pertussis vaccine: 1990.
    Mortimer EA
    Adv Pediatr Infect Dis; 1990; 5():1-33. PubMed ID: 2183817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.